K-numberK251155
Device nameBD Cathena™ Safety IV Catheter
ApplicantBecton Dickinson Infusion Therapy Systems, Inc.
Product codeFOZ
Device classClass II
Decision dateJul 11, 2025
DecisionSubstantially Equivalent
Regulation880.5200
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The BD Cathena™ Safety IV Catheter is an over-the-needle peripheral intravascular catheter intended for short-term use to sample blood, monitor blood pressure, or administer fluids. It includes a radiopaque catheter, passive safety needle shield, flash chamber, and is available with or without multi-access blood control technology and wings. The device is suitable for use with power injectors up to 325 psi.

Technological characteristics

The subject device uses identical fundamental technology to the predicate: a peripheral intravascular catheter with passive needlestick safety mechanism, multi-use blood control septum (optional), and BD Instaflash™ technology for flashback visualization. Primary material composition is substantially equivalent except for a new green colorant supplier (same CAS# and concentration) and a new needle lubricant supplier (same chemistry, molecular weight, and viscosity). All catheter dimensions, gauges, lengths, and product configurations remain identical.

Test standards cited

ISO 11135 (sterilization by ethylene oxide), ISO 10993-7 (biocompatibility), ISO 80369-7 (small-bore connectors), and ISO 14971:2019 (risk management). Internal performance testing included frequency response, kink resistance, blood fill time, average system drag, air vent time, procedural leak time, and instaflash time.

Substantial equivalence argument

The device is substantially equivalent because it has identical indications for use, identical fundamental scientific technology and operating principles, and identical catheter dimensions and configurations to the predicate device (K220584). The only material composition changes are supplier qualifications for the green colorant and needle lubricant, which maintain identical chemistry and specifications. Design verification testing confirmed these supplier changes do not affect device performance, and all performance testing met predetermined acceptance criteria, demonstrating functional equivalence to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →